Taysha Gene Therapies Announces Queen’s University’s Receipt of Clinical Trial Application …,

TSHA-101 to be first bicistronic vector evaluated in human clinical trials; TSHA-101 designed to deliver both HEXA and HEXB transgenes within a …, TSHA-101 to be first bicistronic vector evaluated in human clinical trials; TSHA-101 designed to deliver both HEXA and HEXB transgenes within a …, Read More

Scroll to Top